NADPH oxidases in the vasculature: Molecular features, roles in disease and pharmacological inhibition

Pharmacology and Therapeutics

Volumn 120, Issue 3, 2008, Pages 254-291

  Selemidis, Stavros ^a   Sobey, Christopher G ^a   Wingler, Kirstin ^a   Schmidt, Harald H H W ^a   Drummond, Grant R ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Cardiovascular disease; Endothelium; NADPH oxidase; Pharmacology; Superoxide

Indexed keywords

4 (2 AMINOETHYL)BENZENESULFONYL FLUORIDE; ALPHA TOCOPHEROL; APOCYNIN; BENZYL ISOTHIOCYANATE; BILIRUBIN; CLOSTRIDIUM DIFFICILE TOXIN B; COMPACTIN; CURCUMIN; DIPHENYLIODONIUM SALT; GHRELIN; GLIOTOXIN; GUANETHIDINE; LOSARTAN; MASTOPARAN; MECAMYLAMINE; METFORMIN; MINOCYCLINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEBIVOLOL; NORDIHYDROGUAIARETIC ACID; PERHEXILINE; PR 39; PROBUCOL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RESERPINE; RESVERATROL; ROXITHROMYCIN; SILDENAFIL; TETRODOTOXIN; UNINDEXED DRUG;

DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG INHIBITION; DRUG STRUCTURE; HEART INFARCTION; HYPERCHOLESTEROLEMIA; HYPERTENSION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; STROKE; VASCULARIZATION;

ANIMALS; BLOOD VESSELS; ENZYME INHIBITORS; HUMANS; MODELS, BIOLOGICAL; NADPH OXIDASE; REACTIVE OXYGEN SPECIES; VASCULAR DISEASES;

EID: 56149093044     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2008.08.005     Document Type: Review

References (406)

1. Abdelghaffar H., Babin-Chevaye C., and Labro M.T. The macrolide roxithromycin impairs NADPH oxidase activation and alters translocation of its cytosolic components to the neutrophil membrane in vitro. Antimicrob Agents Chemother 49 7 (2005) 2986-2989
2. Abid M.R., Kachra Z., Spokes K.C., and Aird W.C. NADPH oxidase activity is required for endothelial cell proliferation and migration. FEBS Lett 486 3 (2000) 252-256
3. Abo A., Pick E., Hall A., Totty N., Teahan C.G., and Segal A.W. Activation of the NADPH oxidase involves the small GTP-binding protein p21rac1. Nature 353 6345 (1991) 668-670
4. Agerberth B., Lee J.Y., Bergman T., Carlquist M., Boman H.G., Mutt V., et al. Amino acid sequence of PR-39. Isolation from pig intestine of a new member of the family of proline-arginine-rich antibacterial peptides. Eur J Biochem 202 (1991) 849-854
5. Ago T., Kitazono T., Kuroda J., Kumai Y., Kamouchi M., Ooboshi H., et al. NAD(P)H oxidases in rat basilar arterial endothelial cells. Stroke 36 5 (2005) 1040-1046
6. Ago T., Kitazono T., Ooboshi H., Iyama T., Han Y.H., Takada J., et al. Nox4 as the major catalytic component of an endothelial NAD(P)H oxidase. Circulation 109 2 (2004) 227-233
7. Ago T., Kuribayashi F., Hiroaki H., Takeya R., Ito T., Kohda D., et al. Phosphorylation of p47phox directs phox homology domain from SH3 domain toward phosphoinositides, leading to phagocyte NADPH oxidase activation. PNAS 100 8 (2003) 4474-4479
8. Ago T., Nunoi H., Ito T., and Sumimoto H. Mechanism for phosphorylation-induced activation of the phagocyte NADPH oxidase protein p47phox. Triple replacement of serines 303, 304, and 328 with aspartates disrupts the SH3 domain-mediated intramolecular interaction in p47(phox), thereby activating the oxidase. J Biol Chem 274 47 (1999) 33644-33653
9. Ago T., Takeya R., Hiroaki H., Kuribayashi F., Ito T., Kohda D., et al. The PX domain as a novel phosphoinositide-binding module. Biochem Biophys Res Commun 287 3 (2001) 733-738
10. Agwuh K.N., and MacGowan A. Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines. J Antimicrob Chemother 58 2 (2006) 256-265
11. Al-Mehdi A.B., Zhao G., Dodia C., Tozawa K., Costa K., Muzykantov V., et al. Endothelial NADPH oxidase as the source of oxidants in lungs exposed to ischemia or high K+. Circ Res 83 7 (1998) 730-737
12. Allison A.C., and Eugui E.M. Mycophenolate mofetil and its mechanisms of action. Immunopharmacology 47 2-3 (2000) 85-118
13. Alp N.J., and Channon K.M. Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease. Arterioscler Thromb Vasc Biol 24 3 (2004) 413-420
14. Ambasta R.K., Kumar P., Griendling K.K., Schmidt H.H.H.W., Busse R., and Brandes R.P. Direct interaction of the novel Nox proteins with p22phox is required for the formation of a functionally active NADPH oxidase. J Biol Chem 279 44 (2004) 45935-45941
15. Anderson R. Erythromycin and roxithromycin potentiate human neutrophil locomotion in vitro by inhibition of leukoattractant-activated superoxide generation and autooxidation. J Infect Dis 159 (1989) 966-973
16. Ando S., Kaibuchi K., Sasaki T., Hiraoka K., Nishiyama T., Mizuno T., et al. Post-translational processing of rac p21s is important both for their interaction with the GDP/GTP exchange proteins and for their activation of NADPH oxidase. J Biol Chem 267 36 (1992) 25709-25713
17. Ashrafian H., Horowitz J.D., and Frenneaux M.P. Perhexiline. Cardiovasc Drug Rev 25 1 (2007) 76-97
18. Babior B., and Kipnes R. Superoxide-forming enzyme from human neutrophils: evidence for a flavin requirement. Blood 50 3 (1977) 517-524
19. Babior B.M., Kipnes R.S., and Curnutte J.T. Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. J Clin Invest 52 (1973) 741-744
20. Babior B.M., Lambeth J.D., and Nauseef W. The neutrophil NADPH oxidase. Arch Biochem Biophys 397 (2002) 342-344
21. Bae J.S., Yang L., and Rezaie A.R. Receptors of the protein C activation and activated protein C signaling pathways are colocalized in lipid rafts of endothelial cells. Proc Natl Acad Sci 104 8 (2007) 2867-2872
22. Baldrigde C.W., and Gerard R.W. The extra respiration of phagocytosis. Am J Physiol 103 (1933) 235-236
23. Banfi B., Clark R.A., Steger K., and Krause K.H. Two novel proteins activate superoxide generation by the NADPH oxidase NOX1. J Biol Chem 278 (2003) 3510-3513
24. Banfi B., Malgrange B., Knisz J., Steger K., Dubois-Dauphin M., and Krause K.H. NOX3, a superoxide-generating NADPH oxidase of the inner ear. J Biol Chem 279 44 (2004) 46065-46072
25. Banfi B., Maturana A., Jaconi S., Arnaudeau S., Laforge T., Sinha B., et al. A Mammalian H+ channel generated through alternative splicing of the NADPH oxidase homolog NOH-1. Science 287 5450 (2000) 138-142
26. Banfi B., Molnar G., Maturana A., Steger K., Hegedus B., Demaurex N., et al. A Ca2+-activated NADPH oxidase in testis, spleen, and lymph nodes. J Biol Chem 276 40 (2001) 37594-37601
27. Bao J., Sato K., Li M., Gao Y., Abid R., Aird W., et al. PR-39 and PR-11 peptides inhibit ischemia-reperfusion injury by blocking proteasome-mediated Ikappa Balpha degradation. Am J Physiol Heart Circ Physiol 281 6 (2001) H2612-H2618
28. Barry-Lane P.A., Patterson C., van der Merwe M., Hu Z., Holland S.M., Yeh E.T., et al. p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice. J Clin Invest 108 10 (2001) 1513-1522
29. Barua M., Liu Y., and Quinn M.R. Taurine chloramine inhibits inducible nitric oxide synthase and TNF-{alpha} gene expression in activated alveolar macrophages: decreased NF-{kappa}B activation and I{kappa}B kinase activity. J Immunol 167 4 (2001) 2275-2281
30. Basu K., Dasgupta B., Bhattacharya S.K., and Debnath P.K. Chemistry and pharmacology of apocynin, isolated from Picrorhiza kurroa Royle ex Benth. Curr Sci 40 22 (1971) 603-604
31. Baumer A.T., Kruger C.A., Falkenberg J., Ten Freyhaus H., Rosen R., Fink K., et al. The NAD(P)H oxidase inhibitor apocynin improves endothelial NO/superoxide balance and lowers effectively blood pressure in spontaneously hypertensive rats: comparison to calcium channel blockade. Clin Exp Hypertens 29 5 (2007) 287-299
32. Bayraktutan U., Blayney L., and Shah A.M. Molecular characterization and localization of the NAD(P)H oxidase components gp91-phox and p22-phox in endothelial cells. Arterioscler Thromb Vasc Biols 20 8 (2000) 1903-1911
33. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., and Freeman B.A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. PNAS 87 4 (1990) 1620-1624
34. BelAiba R.S., Djordjevic T., Petry A., Diemer K., Bonello S., Banfi B., et al. NOX5 variants are functionally active in endothelial cells. Free Radic Biol Med 42 4 (2007) 446-459
35. Bengtsson S.H., Gulluyan L.M., Dusting G.J., and Drummond G.R. Novel isoforms of NADPH oxidase in vascular physiology and pathophysiology. Clin Exp Pharmacol Physiol 30 11 (2003) 849-854
36. Beswick R.A., Dorrance A.M., Leite R., and Webb R.C. NADH/NADPH oxidase and enhanced superoxide production in the mineralocorticoid hypertensive rat. Hypertension 38 5 (2001) 1107-1111
37. Bette P., Oksche A., Mauler F., von Eichel-Streiber C., Popoff M.R., and Habermann E. A comparative biochemical, pharmacological and immunological study of Clostridium novyi alpha-toxin, C. difficile toxin B and C. sordellii lethal toxin. Toxicon 29 7 (1991) 877-887
38. Bey E.A., and Cathcart M.K. In vitro knockout of human p47phox blocks superoxide anion production and LDL oxidation by activated human monocytes. J Lipid Res 41 3 (2000) 489-495
39. Bishop A.L., and Hall A. Rho GTPases and their effector proteins. Biochem J 348 2 (2000) 241-255
40. Bissonnette S.A., Glazier C.M., Stewart M.Q., Brown G.E., Ellson C.D., and Yaffe M.B. Phosphatidylinositol 3-phosphate-dependent and -independent functions of p40phox in activation of the neutrophil NADPH oxidase. J Biol Chem 283 4 (2008) 2108-2119
41. Blankenhorn D.H., Azen S.P., Kramsch D.M., Mack W.J., Cashin-Hemphill L., Hodis H.N., et al. Coronary angiographic changes with lovastatin therapy: the Monitored Atherosclerosis Regression Study (MARS). Ann Intern Med 119 10 (1993) 969-976
42. Bokoch G.M. Regulation of phagocyte function by low molecular weight GTP-binding proteins. Eur J Haematol 51 5 (1993) 313-317
43. Bokoch G.M., and Prossnitz V. Isoprenoid metabolism is required for stimulation of the respiratory burst oxidase of HL-60 cells. J Clin Invest 89 2 (1992) 402-408
44. Bonnefont-Rousselot D., Raji B., Walrand S., Gards-Albert M., Jore D., Legrand A., et al. An intracellular modulation of free radical production could contribute to the beneficial effects of metformin towards oxidative stress. Metabolism 52 5 (2003) 586-589
45. Boring L., Gosling J., Cleary M., and Charo I.F. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394 6696 (1998) 894-897
46. Bourne H.R., Sanders D.A., and McCormick F. The GTPase superfamily: a conserved switch for diverse cell functions. Nature 348 6297 (1990) 125-132
47. Bourne H.R., Sanders D.A., and McCormick F. The GTPase superfamily: conserved structure and molecular mechanism. Nature 349 6305 (1991) 117-127
48. Boveris A., and Cadenas E. Mitochondrial production of superoxide anions and its relationship to the antimycin insensitive respiration. FEBS Letters 54 3 (1975) 311-314
49. Brandes R.P., Miller F.J., Beer S., Haendeler J., Hoffmann J., Ha T., et al. The vascular NADPH oxidase subunit p47phox is involved in redox-mediated gene expression. Free Radic Biol Med 32 11 (2002) 1116-1122
50. Brandsch R., and Bichler V. Covalent flavinylation of 6-hydroxy-d-nicotine oxidase involves an energy-requiring process. FEBS Letters 224 1 (1987) 121-124
51. Burritt J.B., DeLeo F.R., McDonald C.L., Prigge J.R., Dinauer M.C., Nakamura M., et al. Phage display epitope mapping of human neutrophil flavocytochrome b558. Identification of two juxtaposed extracellular domains. J Biol Chem 276 3 (2001) 2053-2061
52. Burritt J.B., Foubert T.R., Baniulis D., Lord C.I., Taylor R.M., Mills J.S., et al. Functional epitope on human neutrophil flavocytochrome b558. J Immunol 170 12 (2003) 6082-6089
53. Buul J.D.V., Fernandez-Borja M., Anthony E.C., and Hordijk P.L. Expression and localization of NOX2 and NOX4 in primary human endothelial cells. Antioxid Redox Signal 7 3-4 (2005) 308-317
54. Byrne J.A., Grieve D.J., Bendall J.K., Li J.M., Gove C., Lambeth J.D., et al. Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy. Circ Res 93 9 (2003) 802-805
55. Cachia O., Benna J.E., Pedruzzi E., Descomps B., Gougerot-Pocidalo M.A., and Leger C.L. Alpha-tocopherol inhibits the respiratory burst in human monocytes. Attenuation of p47phox membrane translocation and phosphorylation. J Biol Chem 273 49 (1998) 32801-32805
56. Cai H., Griendling K.K., and Harrison D.G. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol Sci 24 (2003) 471-478
57. Cathcart M.K. Regulation of superoxide anion production by NADPH oxidase in monocytes/macrophages: contributions to atherosclerosis. Arterioscler Thromb Vasc Biol 24 1 (2004) 23-28
58. Cathcart M.K., McNally A.K., Morel D.W., and Chisolm G.M.d. Superoxide anion participation in human monocyte-mediated oxidation of low-density lipoprotein and conversion of low-density lipoprotein to a cytotoxin. J Immunol 142 6 (1989) 1963-1969
59. Cayatte A.J., Rupin A., Oliver-Krasinski J., Maitland K., Sansilvestri-Morel P., Boussard M.F., et al. S17834, a new inhibitor of cell adhesion and atherosclerosis that targets NADPH oxidase. Arterioscler Thromb Vasc Biol 21 10 (2001) 1577-1584
60. Cernuda-Morollon E., and Ridley A.J. Rho GTPases and leukocyte adhesion receptor expression and function in endothelial cells. Circulation Research 98 6 (2006) 757-767
61. Chamseddine A.H., and Miller Jr. F.J. Gp91phox contributes to NADPH oxidase activity in aortic fibroblasts but not smooth muscle cells. Am J Physiol Heart Circ Physiol 285 6 (2003) H2284-2289
62. Chance B., Sies H., and Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol Rev 59 3 (1979) 527-605
63. Cheng G., Cao Z., Xu X., Meir E.G.V., and Lambeth J.D. Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5. Gene 269 1-2 (2001) 131-140
64. Cheng G., Diebold B.A., Hughes Y., and Lambeth J.D. Nox1-dependent reactive oxygen generation is regulated by Rac1. J Biol Chem 281 26 (2006) 17718-17726
65. Cheng G., and Lambeth J.D. NOXO1, regulation of lipid binding, localization, and activation of Nox1 by the Phox homology (PX) domain. J Biol Chem 279 6 (2004) 4737-4742
66. Cheng G., and Lambeth J.D. Alternative mRNA splice forms of NOXO1: differential tissue expression and regulation of Nox1 and Nox3. Gene 356 (2005) 118-126
67. Choi H.S., Cha Y.N., and Kim C. Taurine chloramine inhibits PMA-stimulated superoxide production in human neutrophils perhaps by inhibiting phosphorylation and translocation of p47(phox). Int Immunopharmacol 9 (2006) 1431-1440
68. Choi S.H., Lee D.Y., Chung E.S., Hong Y.B., Kim S.U., and Jin B.K. Inhibition of thrombin-induced microglial activation and NADPH oxidase by minocycline protects dopaminergic neurons in the substantia nigra in vivo. J Neurochem 95 6 (2005) 1755-1765
69. Cifuentes M.E., Rey F.E., Carretero O.A., and Pagano P.J. Upregulation of p67phox and gp91phox in aortas from angiotensin II-infused mice. Am J Physiol Heart Circ Physiol 279 5 (2000) H2234-H2240
70. Clempus R.E., Sorescu D., Dikalova A.E., Pounkova L., Jo P., Sorescu G.P., et al. Nox4 is required for maintenance of the differentiated vascular smooth muscle cell phenotype. Arterioscler Thromb Vasc Biol 27 1 (2007) 42-48
71. Coles B., Bloodsworth A., Clark S.R., Lewis M.J., Cross A.R., Freeman B.A., et al. Nitrolinoleate inhibits superoxide generation, degranulation, and integrin expression by human neutrophils: novel antiinflammatory properties of nitric oxide-derived reactive species in vascular cells. Circ Res 91 5 (2002) 375-381
72. Comera C., Andre K., Laffitte J., Collet X., Galtier P., and Maridonneau-Parini I. Gliotoxin from Aspergillus fumigatus affects phagocytosis and the organization of the actin cytoskeleton by distinct signalling pathways in human neutrophils. Microbes Infect 9 1 (2007) 47-54
73. Cooper J.M., Petty R.K., Hayes D.J., Challiss R.A., Brosnan M.J., Shoubridge E.A., et al. An animal model of mitochondrial myopathy: a biochemical and physiological investigation of rats treated in vivo with the NADH-CoQ reductase inhibitor, diphenyleneiodonium. J Neurorol Sci 83 2-3 (1988) 335-347
74. Cross A.R., and Jones O.T. The effect of the inhibitor diphenylene iodonium on the superoxide-generating system of neutrophils. Specific labelling of a component polypeptide of the oxidase. Biochem J 237 (1986) 111-116
75. Cross A.R., Parkinson J.F., and Jones O.T. The superoxide-generating oxidase of leucocytes. NADPH-dependent reduction of flavin and cytochrome b in solubilized preparations. Biochem J 223 2 (1984) 337-344
76. 2, and high intravascular pressure. Circulation 111 18 (2005) 2364-2372
77. Cui X.L., Brockman D., Campos B., and Myatt L. Expression of NADPH oxidase isoform 1 (Nox1) in human placenta: involvement in preeclampsia. Placenta 27 4-5 (2006) 422-431
78. D'Alessio A., Al-Lamki R.S., Bradley J.R., and Pober J.S. Caveolae participate in tumor necrosis factor receptor 1 signaling and internalization in a human endothelial cell line. Am J Pathol 166 4 (2005) 1273-1282
79. de Mendez I., Adams A.G., Sokolic R.A., Malech H.L., and Leto T.L. Multiple SH3 domain interactions regulate NADPH oxidase assembly in whole cells. EMBO J 15 6 (1996) 1211-1220
80. de Mendez I., Homayounpour N., and Leto T.L. Specificity of p47phox SH3 domain interactions in NADPH oxidase assembly and activation. Mol Cell Biol 17 4 (1997) 2177-2185
81. Deby-Dupont G., Mouithys-Mickalad A., Serteyn D., Lamy M., and Deby C. Resveratrol and curcumin reduce the respiratory burst of Chlamydia-primed THP-1 cells. Biochem Biophys Res Commun 333 1 (2005) 21-27
82. DeLeo F.R., Burritt J.B., Yu L., Jesaitis A.J., Dinauer M.C., and Nauseef W.M. Processing and maturation of flavocytochrome b558 include incorporation of heme as a prerequisite for heterodimer assembly. J Biol Chem 275 18 (2000) 13986-13993
83. DeLeo F.R., Yu L., Burritt J.B., Loetterle L.R., Bond C.W., Jesaitis A.J., et al. Mapping sites of interaction of p47-Phox and flavocytochrome b with random-sequence peptide phage display libraries. PNAS 92 15 (1995) 7110-7114
84. Di-Poi N., Faure J., Grizot S., Molnar G., Pick E., and Dagher M.C. Mechanism of NADPH oxidase activation by the Rac/Rho-GDI complex. Biochemistry 40 34 (2001) 10014-10022
85. Diatchuk V., Lotan O., Koshkin V., Wikstroem P., and Pick E. Inhibition of NADPH oxidase activation by 4-(2-Aminoethyl)-benzenesulfonyl fluoride and related compounds. J Biol Chem 272 20 (1997) 13292-13301
86. Didsbury J.R., Uhing R.J., and Snyderman R. Isoprenylation of the low molecular mass GTP-binding proteins rac 1 and rac 2: possible role in membrane localization. Biochem Biophys Res Commun 171 2 (1990) 804-812
87. Diekmann D., Abo A., Johnston C., Segal A.W., and Hall A. Interaction of Rac with p67phox and regulation of phagocytic NADPH oxidase activity. Science 5171 265 (1994) 531-533
88. Dikalova A., Clempus R., Lassegue B., Cheng G., McCoy J., Dikalov S., et al. Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice. Circulation 112 17 (2005) 2668-2676
89. Dinauer M.C. Regulation of neutrophil function by Rac GTPases. Curr Opin Hematol 10 1 (2003) 8-15
90. Dinauer M.C., Pierce E.A., Erickson R.W., Muhlebach T.J., Messner H., Orkin S.H., et al. Point mutation in the cytoplasmic domain of the neutrophil p22-phox cytochrome b subunit is associated with a nonfunctional NADPH oxidase and chronic granulomatous disease. PNAS 88 24 (1991) 11231-11235
91. Dorseuil O., Quinn M.T., and Bokoch G.M. Dissociation of Rac translocation from p47phox/p67phox movements in human neutrophils by tyrosine kinase inhibitors. J Leukoc Biol 58 1 (1995) 108-113
92. Dourron H.M., Jacobson G.M., Park J.L., Liu J., Reddy D.J., Scheel M.L., et al. Perivascular gene transfer of NADPH oxidase inhibitor suppresses angioplasty-induced neointimal proliferation of rat carotid artery. Am J Physiol Heart Circ Physiol 288 2 (2005) H946-H953
93. Doussiere J., Gaillard J., and Vignais P.V. Electron transfer across the O2- generating flavocytochrome b of neutrophils. Evidence for a transition from a low-spin state to a high-spin state of the heme iron component. Biochemistry 35 41 (1996) 13400-13410
94. Doussiere J., Pilloud M.C., and Vignais P.V. Activation of bovine neutrophil oxidase in a cell free system. GTP-dependent formation of a complex between a cytosolic factor and a membrane protein. Biochem Biophys Res Commun 152 3 (1988) 993-1001
95. Duerrschmidt N., Stielow C., Muller G., Pagano P.J., and Morawietz H. NO-mediated regulation of NAD(P)H oxidase by laminar shear stress in human endothelial cells. J Physiol (Lond) 576 (2006) 557-567
96. Duerrschmidt N., Wippich N., Goettsch W., Broemme H.J., and Morawietz H. Endothelin-1 induces NAD(P)H oxidase in human endothelial cells. Biochem Biophys Res Commun 269 3 (2000) 713-717
97. Egger T., Hammer A., Wintersperger A., Goti D., Malle E., and Sattler W. Modulation of microglial superoxide production by alpha-tocopherol in vitro: attenuation of p67phox translocation by a protein phosphatase-dependent pathway. J Neurochem 79 6 (2001) 1169-1182
98. El Benna J., Faust F.R., Johnson J.L., and Babior B.M. Phosphorylation of the respiratory burst oxidase subunit p47phox as determined by two-dimensional phosphopeptide mapping. Phosphorylation by protein kinase C, protein kinase A, and a mitogen-activated protein kinase. J Biol Chem 271 (1996) 6374-6378
99. Ellis J.A., Mayer S., and Jones O.T. The effect of the NADPH oxidase inhibitor diphenyleneiodonium on aerobic and anaerobic microbicidal activities of human neutrophils. Biochem J 251 (1988) 887-891
100. Ellmark S.H.M., Dusting G.J., Ng Tang Fui M., Guzzo-Pernell N., and Drummond G.R. The contribution of Nox4 to NADPH oxidase activity in mouse vascular smooth muscle. Cardiovasc Res 65 2 (2005) 495-504
101. Ellson C.D., Gobert-Gosse S., Anderson K.E., Davidson K., Erdjument-Bromage H., Tempst P., et al. PtdIns(3)P regulates the neutrophil oxidase complex by binding to the PX domain of p40phox. Nat Cell Biol 3 7 (2001) 679-682
102. Elmarakby A.A., Loomis E.D., Pollock J.S., and Pollock D.M. NADPH Oxidase inhibition attenuates oxidative stress but not hypertension produced by chronic ET-1. Hypertension 45 2 (2005) 283-287
103. Engels F., Renirie B.F., Hart B.A., Labadie R.P., and Nijkamp F.P. Effects of apocynin, a drug isolated from the roots of Picrorhiza kurroa, on arachidonic acid metabolism. FEBS Lett 305 6 (1992) 254-256
104. Etienne-Manneville S., and Hall A. Rho GTPases in cell biology. Nature 420 6916 (2002) 629-635
105. Fan C., Katsuyama M., Nishinaka T., and Yabe-Nishimura C. Transactivation of the EGF receptor and a PI3 kinase-ATF-1 pathway is involved in the upregulation of NOX1, a catalytic subunit of NADPH oxidase. FEBS Lett 579 5 (2005) 1301-1305
106. Fang J., Lu J., and Holmgren A. Thioredoxin reductase is irreversibly modified by curcumin: a novel molecular mechanism for its anticancer activity. J Biol Chem 280 26 (2005) 25284-25290
107. Finan P., Shimizu Y., Gout I., Hsuan J., Truong O., Butcher C., et al. An SH3 domain and proline-rich sequence mediate an interaction between two components of the phagocyte NADPH oxidase complex. J Biol Chem 269 19 (1994) 13752-13755
108. Finegold A.A., Shatwell K.P., Segal A.W., Klausner R.D., and Dancis A. Intramembrane bis-heme motif for transmembrane electron transport conserved in a yeast iron reductase and the human NADPH oxidase. J Biol Chem 271 49 (1996) 31021-31024
109. Fontayne A., DP, Gougerot-Pocidalo M.A., and El-Benna J. Phosphorylation of p47phox sites by PKC alpha, beta II, delta, and zeta: effect on binding to p22phox and on NADPH oxidase activation. Biochemistry 41 (2002) 7743-7750
110. Freeman J.L., and Lambeth J.D. NADPH oxidase activity is independent of p47phox in vitro. J Biol Chem 271 37 (1996) 22578-22582
111. Fuchs A., Dagher M.C., and Vignais P.V. Mapping the domains of interaction of p40phox with both p47phox and p67phox of the neutrophil oxidase complex using the two-hybrid system. J Biol Chem 270 11 (1995) 5695-5697
112. Furberg C.D., Adams H.P.J., Applegate W.B., Byington R.P., Espeland M.A., Hartwell T., et al. Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group. Circulation 90 4 (1994) 1679-1687
113. Gabig T.G., English D., Akard L.P., and Schell M.J. Regulation of neutrophil NADPH oxidase activation in a cell-free system by guanine nucleotides and fluoride. Evidence for participation of a pertussis and cholera toxin-insensitive G protein. J Biol Chem 262 4 (1987) 1685-1690
114. Gajewska R., Ganowiak Z., Grzybowski J., Radecki A., and Wrzesniowska. Analysis of an industrial smoke preparation. Bromat Chem Toksykol XIV (1981) 3-4
115. Gatley S.J., and Martin J.L. Some aspects of the pharmacology of diphenyleneiodonium, a bivalent iodine compound. Xenobiotica 9 9 (1979) 539-546
116. Gatley S.J., and Sherratt H.S. The effects of diphenyleneiodonium and of 2,4-dichlorodiphenyleneiodonium on mitochondrial reactions. Mechanism of the inhibition of oxygen uptake as a consequence of the catalysis of the chloride/hydroxyl-ion exchange. Biochem J 158 (1976) 317-326
117. Gavazzi G., Banfi B., Deffert C., Fiette L., Schappi M., Herrmann F., et al. Decreased blood pressure in NOX1-deficient mice. FEBS Lett 580 2 (2006) 497-504
118. Gavazzi G., Deffert C., Trocme C., Schappi M., Herrmann F.R., and Krause K.H. NOX1 deficiency protects from aortic dissection in response to angiotensin II. Hypertension 50 1 (2007) 189-196
119. Geiszt M., Kopp J.B., Varnai P., and Leto T.L. Identification of Renox, an NAD(P)H oxidase in kidney. PNAS 97 14 (2000) 8010-8014
120. Geiszt M., Lekstrom K., Witta J., and Leto T.L. Proteins homologous to p47phox and p67phox support superoxide production by NAD(P)H oxidase 1 in colon epithelial cells. J Biol Chem 278 (2003) 20006-20012
121. George R.H., Symonds J.M., Dimock F., Brown J.D., Arabi Y., Shinagawa N., et al. Identification of Clostridium difficile as a cause of pseudomembranous colitis. Br Med J 18 1 (1978) 695
122. Girouard H., Park L., Anrather J., Zhou P., and Iadecola C. Angiotensin II attenuates endothelium-dependent responses in the cerebral microcirculation through Nox-2-derived radicals. Arterioscler Thromb Vasc Biol 26 4 (2006) 826-832
123. Glorioso N., Troffa C., Filigheddu F., Dettori F., Soro A., Parpaglia P.P., et al. Effect of the HMG-CoA reductase inhibitors on blood pressure in patients with essential hypertension and primary hypercholesterolemia. Hypertension 34 6 (1999) 1281-1286
124. Goldstein J.L., and Brown M.S. Regulation of the mevalonate pathway. Nature 343 6257 (1990) 425-430
125. Gorin Y., Ricono J.M., Kim N.H., Bhandari B., Choudhury G.G., and Abboud H.E. Nox4 mediates angiotensin II-induced activation of Akt/protein kinase B in mesangial cells. Am J Physiol Renal Physiol 285 2 (2003) F219-229
126. Gorlach A., Brandes R.P., Nguyen K., Amidi M., Dehghani F., and Busse R. A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ Res 87 1 (2000) 26-32
127. Gorzalczany Y., Alloul N., Sigal N., Weinbaum C., and Pick E. A prenylated p67phox-Rac1 chimera elicits NADPH-dependent superoxide production by phagocyte membranes in the absence of an activator and of p47phox: conversion of a pagan NADPH oxidase to monotheism. J Biol Chem 277 (2002) 18605-18610
128. Gould A.L., Rossouw J.E., Santanello N.C., Heyse J.F., and Furberg C.D. Cholesterol reduction yields clinical benefit: impact of statin trials. Circulation 97 10 (1998) 946-952
129. Goyal P., Weissmann N., Rose F., Grimminger F., Schafers H.J., Seeger W., et al. Identification of novel Nox4 splice variants with impact on ROS levels in A549 cells. Biochem Biophys Res Commun 329 1 (2005) 32-39
130. Griendling K.K., Minieri C.A., Ollerenshaw J.D., and Alexander R.W. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74 6 (1994) 1141-1148
131. Groemping Y., Lapouge K., Smerdon S.J., and Rittinger K. Molecular basis of phosphorylation-induced activation of the NADPH oxidase. Cell 113 3 (2003) 343-355
132. Groemping Y., and Rittinger K. Activation and assembly of the NADPH oxidase: a structural perspective. Biochem J 386 3 (2005) 401-416
133. Gu L., Okada Y., Clinton S.K., Gerard C., Sukhova G.K., Libby P., et al. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell 2 1 (1998) 275-281
134. Guzik T.J., Hoch N.E., Brown K.A., McCann L.A., Rahman A., Dikalov S., et al. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med 204 10 (2007) 2449-2460
135. Guzik T.J., Sadowski J., Guzik B., Jopek A., Kapelak B., Przybylowski P., et al. Coronary artery superoxide production and Nox isoform expression in human coronary artery disease. Arterioscler Thromb Vasc Biol 26 (2006) 333-339
136. Haber F., and Weiss J. On the catalysis of hydroperoxide. Naturwissenschaften 20 (1932) 948-950
137. Hall I.C., and O' Toole E. Intestinal flora in newborn infants with description of a new pathogenic anaerobe. Bacillus difficilis. Amer J Dis Child 49 (1935) 390-402
138. Han C.H., Freeman J.L.R., Lee T., Motalebi S.A., and Lambeth J.D. Regulation of the neutrophil respiratory burst oxidase. Identification Of An Activation Domain In p67phox. J Biol Chem 273 27 (1998) 16663-16668
139. Hancock J.T., and Jones O.T. The inhibition by diphenyleneiodonium and its analogues of superoxide generation by macrophages. Biochem J 242 (1987) 103-107
140. Hanna I.R., Hilenski L.L., Dikalova A., Taniyama Y., Dikalov S., Lyle A., et al. Functional association of nox1 with p22phox in vascular smooth muscle cells. Free Radic Biol Med 37 10 (2004) 1542-1549
141. Harfouche R., Abdel-Malak N.A., Brandes R.P., Karsan A., Irani K., and Hussain S.N.A. Roles of reactive oxygen species in angiopoietin-1/tie-2 receptor signaling. FASEB J 19 12 (2005) 1728-1730
142. Harper A., Chaplin M., and Segal A. Cytochrome b-245 from human neutrophils is a glycoprotein. Biochem J 227 3 (1985) 783-788
143. Hathaway C.A., Heistad D.D., Piegors D.J., and Miller Jr. F.J. Regression of atherosclerosis in monkeys reduces vascular superoxide levels. Circ Res 90 3 (2002) 277-283
144. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20[punctuation space]536 high-risk individuals: a randomised placebocontrolled trial. Lancet 360 9326 (2002) 7-22
145. Heyworth P.G., Bohl B.P., Bokoch G.M., and Curnutte J.T. Rac translocates independently of the neutrophil NADPH oxidase components p47phox and p67phox. Evidence for its interaction with flavocytochrome b558. J Biol Chem 269 49 (1994) 30749-30752
146. Heumüller S., Wind S., Barbosa-Sicard E., Schmidt H.H., Busse R., Schröder K., et al. Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant. Hypertension 51 (2008) 211-217
147. Hofmann F., Busch C., Prepens U., Just I., and Aktories K. Localization of the glucosyltransferase activity of Clostridium difficile toxin B to the N-terminal part of the holotoxin. J Biol Chem 272 17 (1997) 11074-11078
148. Hohler B., Holzapfel B., and Kummer W. NADPH oxidase subunits and superoxide production in porcine pulmonary artery endothelial cells. Histochem Cell Biol 114 1 (2000) 29-37
149. Holland, J. A., & Johnson, D. K. (1999). Prevention of atherosclerosis using NADPH oxidase inhibitors, in United States Patent, United States.
150. Holland J.A., Meyer J.W., Chang M.M., O'Donnell R.W., Johnson D.K., and Ziegler L.M. Thrombin stimulated reactive oxygen species production in cultured human endothelial cells. Endothelium 6 (1998) 113-121
151. Holland J.A., Meyer J.W., Schmitt M.E., Sauro M.D., Johnson D.K., Abdul-Karim R.W., et al. Low-density lipoprotein stimulated peroxide production and endocytosis in cultured human endothelial cells: mechanisms of action. Endothelium 3 (1997) 191-207
152. Holland P.C., Clark M.G., Bloxham D.P., and Lardy H.A. Mechanism of action of the hypoglycemic agent diphenyleneiodonium. J Biol Chem 248 17 (1973) 6050-6056
153. Holland P.C., and Sherratt H.S. Biochemical effects of hypoglycaemic compound diphenyleneiodonium in rat liver mitochondria: inhibition of adenosine triphosphate synthesis. Biochem J 121 3 (1971) 42P
154. Honbou K., Minakami R., Yuzawa S., Takeya R., Suzuki N.N., Kamakura S., et al. Full-length p40phox structure suggests a basis for regulation mechanism of its membrane binding. EMBO J 26 (2007) 1176-1186
155. Hsich E., Segal B.H., Pagano P.J., Rey F.E., Paigen B., Deleonardis J., et al. Vascular effects following homozygous disruption of p47(phox): an essential component of NADPH oxidase. Circulation 101 (2000) 1234-1236
156. Huang J., Hitt N., and Kleinberg M.E. Stoichiometry of p22-phox and gp91-phox in phagocyte cytochrome b558. Biochemistry 51 34 (1995)
157. Hutchinson D.S., Csikasz R.I., Yamamoto D.L., Shabalina I.G., Wikstrom P., Wilcke M., et al. Diphenylene iodonium stimulates glucose uptake in skeletal muscle cells through mitochondrial complex I inhibition and activation of AMP-activated protein kinase. Cell Signal 19 7 (2007) 1610-1620
158. Imajoh-Ohmi S., Tokita K., Ochiai H., Nakamura M., and Kanegasaki S. Topology of cytochrome b558 in neutrophil membrane analyzed by anti-peptide antibodies and proteolysis. J Biol Chem 267 1 (1992) 180-184
159. Inanami O., Johnson J.L., McAdara J.K., Benna J.E., Faust L.R.P., Newburger P.E., et al. Activation of the leukocyte NADPH oxidase by phorbol ester requires the phosphorylation of p47PHOX on serine 303 or 304. J Biol Chem 273 16 (1998) 9539-9543
160. Inoue N., Ohara Y., Fukai T., Harrison D.G., and Nishida K. Probucol improves endothelial-dependent relaxation and decreases vascular superoxide production in cholesterol-fed rabbits. Am J Med Sci 315 (1998) 242-247
161. Ippoushi K., Itou H., Azuma K., and Higashio H. Effect of naturally occurring organosulfur compounds on nitric oxide production in lipopolysaccharide-activated macrophages. Life Sci 71 4 (2002) 411-419
162. Isogai Y., Iizuka T., and Shiro Y. The mechanism of electron donation to molecular oxygen by phagocytic cytochrome b. J Biol Chem 270 14 (1995) 7853-7857
163. Itoh H., Komori K., Okazaki J., Mawatari K., Kawasaki K., Kuma S., et al. The effect of probucol on intimal thickening of autologous vein grafts in hyperlipidemic rabbit. Cardiovasc Surg 5 5 (1997) 497-503
164. Itoh S., Umemoto S., Hiromoto M., Toma Y., Tomochika Y., Aoyagi S., et al. Importance of NAD(P)H oxidase-mediated oxidative stress and contractile type smooth muscle myosin heavy chain SM2 at the early stage of atherosclerosis. Circulation 105 19 (2002) 2288-2295
165. Iyer G.Y.N., Islam D.M.F., and Quastel J.H. Biochemical aspects of phagocytosis. Nature 192 (1963) 535-542
166. Jacobson G.M., Dourron H.M., Liu J., Carretero O.A., Reddy D.J., Andrzejewski T., et al. Novel NAD(P)H oxidase inhibitor suppresses angioplasty-induced superoxide and neointimal hyperplasia of rat carotid artery. Circ Res 92 (2003) 637-643
167. Jagnandan D., Church J.E., Banfi B., Stuehr D.J., Marrero M.B., and Fulton D.J.R. Novel mechanism of activation of NADPH oxidase 5(NOX5): calcium-sensitization via phosphorylation. J Biol Chem 282 9 (2006) 6494-6507
168. Jank T., Giesemann T., and Aktories K. Rho-glucosylating Clostridium difficile toxins A and B: new insights into structure and function. Glycobiology 17 4 (2007) 15R-22R
169. Jimenez R., Lopez-Sepulveda R., Kadmiri M., Romero M., Vera R., Sanchez M., et al. Polyphenols restore endothelial function in DOCA-salt hypertension: role of endothelin-1 and NADPH oxidase. Free Radic Biol Med 43 3 (2007) 462-473
170. Joberty G., Tavitian A., and Zahraoui A. Isoprenylation of Rab proteins possessing a C-terminal CaaX motif. FEBS Lett 330 3 (1993) 323-328
171. Johnson D.K., Schillinger K.J., Kwait D.M., Hughes C.V., McNamara E.J., Ishmael F., et al. Inhibition of NADPH oxidase activation in endothelial cells by ortho-methoxy-substituted catechols. Endothelium 9 3 (2002) 191-203
172. Jones S., and Howl J. Biological applications of the receptor mimetic peptide mastoparan. Curr Protein Pept Sci 7 (2006) 501-508
173. Jones S.A., O'Donnell V.B., Wood J.D., Broughton J.P., Hughes E.J., and Jones O.T. Expression of phagocyte NADPH oxidase components in human endothelial cells. Am J Physiol Heart Circ Physiol 271 4 (1996) H1626-H1634
174. Jung O., Schreiber J.G., Geiger H., Pedrazzini T., Busse R., and Brandes R.P. gp91phox-containing NADPH oxidase mediates endothelial dysfunction in renovascular hypertension. Circulation 109 14 (2004) 1795-1801
175. Just I., Fritz G., Aktories K., Giry M., Popoff M.R., Boquet P., et al. Clostridium difficile toxin B acts on the GTP-binding protein Rho. J Biol Chem 269 14 (1994) 10706-10712
176. Kahles T., Luedike P., Endres M., Galla H.J., Steinmetz H., Busse R., et al. NADPH oxidase plays a central role in blood-brain barrier damage in experimental stroke. Stroke 38 11 (2007) 3000-3006
177. Kalinina N., Agrotis A., Tararak E., Antropova Y., Kanellakis P., Ilyinskaya O., et al. Cytochrome b558-dependent NAD(P)H oxidase-phox units in smooth muscle and macrophages of atherosclerotic lesions. Arterioscler Thromb Vasc Biol 22 12 (2002) 2037-2043
178. Kalinowski L., Dobrucki I.T., and Malinski T. Race-specific differences in endothelial function: predisposition of African Americans to vascular diseases. Circulation 109 21 (2004) 2511-2517
179. Kami K., Takeya R., Sumimoto H., and Kohda D. Diverse recognition of non-PxxP peptide ligands by the SH3 domains from p67(phox), Grb2 and Pex13p. EMBO J 21 16 (2002) 4268-4276
180. Kanai F., Liu H., Field S.J., Akbary H., Matsuo T., Brown G.E., et al. The PX domains of p47phox and p40phox bind to lipid products of PI(3)K. Nat Cell Biol 3 7 (2001) 675-678
181. Kanno T., Utsumi T., Takehara Y., Ide A., Akiyama J., Yoshioka T., et al. Inhibition of neutrophil-superoxide generation by alpha-tocopherol and coenzyme Q. Free Radic Res 24 (1996) 281-289
182. Katsuyama M., Ozgur Cevik M., Arakawa N., Kakehi T., Nishinaka T., Iwata K., et al. Myocyte enhancer factor 2B is involved in the inducible expression of NOX1/NADPH oxidase, a vascular superoxide-producing enzyme. FEBS Journal 274 19 (2007) 5128-5136
183. Kawahara T., Kuwano Y., Teshima-Kondo S., Takeya R., Sumimoto H., Kishi K., et al. Role of nicotinamide adenine dinucleotide phosphate oxidase 1 in oxidative burst response to toll-like receptor 5 signaling in large intestinal epithelial cells. J Immunol 172 5 (2004) 3051-3058
184. Kawahara T., Ritsick D., Cheng G., and Lambeth J.D. Point mutations in the proline-rich region of p22phox are dominant inhibitors of Nox1- and Nox2-dependent reactive oxygen generation. J Biol Chem 280 36 (2005) 31859-31869
185. Kawczynska-Drozdz A., Olszanecki R., Jawien J., Brzozowski T., Pawlik W.W., Korbut R., et al. Ghrelin inhibits vascular superoxide production in spontaneously hypertensive rats. Am J Hypertens 19 7 (2006) 764-767
186. Keaney Jr. J.F., Xu A., Cunningham D., Jackson T., Frei B., and Vita J.A. Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and superoxide generation. J Clin Invest 95 (1995) 2520-2529
187. Keidar S., Kaplan M., Hoffman A., and Aviram M. Angiotensin II stimulates macrophage-mediated oxidation of low density lipoproteins. Atherosclerosis 115 2 (1995) 201-215
188. Kennedy J.A., Beck-Oldach K., McFadden-Lewis K., Murphy G.A., Wong Y.W., Zhang Y., et al. Effect of the anti-anginal agent, perhexiline, on neutrophil, valvular and vascular superoxide formation. Eur J Pharmacol 531 1-3 (2006) 13-19
189. Kim C., Park E., Quinn M.R., and Schuller-Levis G. The production of superoxide anion and nitric oxide by cultured murine leukocytes and the accumulation of TNF-alpha in the conditioned media is inhibited by taurine chloramine. Immunopharmacology 34 (1996) 89-95
190. Kinsella B.T., Erdman R.A., and Maltese W.A. Carboxyl-terminal isoprenylation of ras-related GTP-binding proteins encoded by rac1, rac2, and ralA. J Biol Chem 266 15 (1991) 9786-9794
191. Kleinberg M.E., Rotrosen D., and Malech H.L. Asparagine-linked glycosylation of cytochrome b558 large subunit varies in different human phagocytic cells. J Immunol 143 12 (1989) 4152-4157
192. Knaus U., Heyworth P., Evans T., Curnutte J., and Bokoch G. Regulation of phagocyte oxygen radical production by the GTP-binding protein Rac 2. Science 254 (1991) 1512-1515
193. Koga H., Terasawa H., Nunoi H., Takeshige K., Inagaki F., and Sumimoto H. Tetratricopeptide repeat (TPR) motifs of p67phox participate in interaction with the small GTPase Rac and activation of the phagocyte NADPH oxidase. J Biol Chem 274 35 (1999) 25051-25060
194. Korthuis R.J., Gute D.C., Blecha F., and Ross C.R. PR-39, a proline/arginine-rich antimicrobial peptide, prevents postischemic microvascular dysfunction. Am J Physiol Heart Circ Physiol 277 3 (1999) H1007-H1013
195. Koshkin V., Lotan O., and Pick E. The cytosolic component p47phox is not a sine qua non participant in the activation of NADPH oxidase but is required for optimal superoxide production. J Biol Chem 271 48 (1996) 30326-30329
196. Koupparis A.J., Jeremy J.Y., Muzaffar S., Persad R., and Shukla N. Sildenafil inhibits the formation of superoxide and the expression of gp47phox NAD[P]H oxidase induced by the thromboxane A2 mimetic, U46619, in corpus cavernosal smooth muscle cells. BJU Int 96 3 (2005) 423-427
197. Krause K.H. Tissue distribution and putative physiological function of NOX family NADPH oxidases. Jpn J Infect Dis 57 5 (2004) S28-29
198. Kreck M.L., Freeman J.L., Abo A., and Lambeth J.D. Membrane association of Rac is required for high activity of the respiratory burst oxidase. Biochemistry 35 49 (1996) 15683-15692
199. Krotz F., Keller M., Derflinger S., Schmid H., Gloe T., Bassermann F., et al. Mycophenolate acid inhibits endothelial NAD(P)H oxidase activity and superoxide formation by a Rac1-dependent mechanism. Hypertension 49 1 (2007) 201-208
200. Kunz A., Anrather J., Zhou P., Orio M., and Iadecola C. Cyclooxygenase-2 does not contribute to postischemic production of reactive oxygen species. J Cereb Blood Flow Metab 27 3 (2006) 545-551
201. Kuribayashi F., Nunoi H., Wakamatsu K., Tsunawaki S., Sato K., Ito T., et al. The adaptor protein p40(phox) as a positive regulator of the superoxide-producing phagocyte oxidase. EMBO J 23 21 (2002) 6312-6320
202. Kwak J.Y., Takeshige K., Cheung B.S., and Minakami S. Bilirubin inhibits the activation of superoxide-producing NADPH oxidase in a neutrophil cell-free system. Biochim Biophys Acta Prot Struct Mol Enzymol 1076 3 (1991) 369-373
203. Kweon Y.O., Paik Y.H., Schnabl B., Qian T., Lemasters J.J., and Brenner D.A. Gliotoxin-mediated apoptosis of activated human hepatic stellate cells. J Hepatol 39 1 (2003) 38-46
204. Lambeth J.D., Kawahara T., and Diebold B. Regulation of Nox and Duox enzymatic activity and expression. Free Radic Biol Med 43 3 (2007) 319-331
205. Landmesser U., Cai H., Dikalov S., McCann L., Hwang J., Jo H., et al. Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension 40 (2002) 511-515
206. Landmesser U., Dikalov S., Price S.R., McCann L., Fukai T., Holland S.M., et al. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest 111 (2003) 1201-1209
207. Lanone S., Bloc S., Foresti R., Almolki A., Taille C., Callebert J., et al. Bilirubin decreases NOS2 expression via inhibition of NAD(P)H oxidase: implications for protection against endotoxic shock in rats. FASEB J 19 43 (2005) 1890-1892
208. Lapouge K., Smith S.J.M., Walker P.A., Gamblin S.J., Smerdon S.J., and Rittinger K. Structure of the TPR domain of p67phox in complex with Rac[middle dot]GTP. Mol Cell 6 4 (2000) 899-907
209. Larson H.E., Price A.B., Honour P., and Borriello S.P. Clostridium difficile and the aetiology of pseudomembranous colitis. Lancet 1 8073 (1978) 1063-1066
210. Lassegue B., and Clempus R.E. Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol 285 (2003) 277-297
211. Lassegue B., Sorescu D., Szocs K., Yin Q., Akers M., Zhang Y., et al. Novel gp91(phox) homologues in vascular smooth muscle cells: nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ Res 88 (2001) 888-894
212. Lavigne M.C., Malech H.L., Holland S.M., and Leto T.L. Genetic demonstration of p47phox-dependent superoxide anion production in murine vascular smooth muscle cells. Circulation 104 1 (2001) 79-84
213. Leiro J., Alvarez E., Arranz J.A., Laguna R., Uriarte E., and Orallo F. Effects of cis-resveratrol on inflammatory murine macrophages: antioxidant activity and down-regulation of inflammatory genes. J Leukoc Biol 75 6 (2004) 1156-1165
214. Leonarduzzi G., Vizio B., Sottero B., Verde V., Gamba P., Mascia C., et al. Early involvement of ROS overproduction in apoptosis induced by 7-ketocholesterol. Antioxid Redox Signal 8 3-4 (2006) 375-380
215. Leto T.L., Adams A.G., and de Mendez I. Assembly of the phagocyte NADPH oxidase: binding of Src homology 3 domains to proline-rich targets. PNAS 91 22 (1994) 10650-10654
216. Leusen J.H., Bolscher B.G., Hilarius P.M., Weening R.S., Kaulfersch W., Seger R.A., et al. 156Pro->Gln substitution in the light chain of cytochrome b558 of the human NADPH oxidase (p22-phox) leads to defective translocation of the cytosolic proteins p47-phox and p67-phox. J Exp Med 180 6 (1994) 2329-2334
217. Li J.M., and Shah A.M. Mechanism of endothelial cell NADPH oxidase activation by angiotensin II. Role of the p47phox subunit. J Biol Chem 278 14 (2003) 12094-12100
218. Liao J.K. Statin therapy: having the good without the bad. Hypertension 43 6 (2004) 1214-1220
219. Ligeti E., Tardif M., and Vignais P. Activation of O2.- generating oxidase of bovine neutrophils in a cell-free system. Interaction of a cytosolic factor with the plasma membrane and control by G nucleotides. Biochemistry 28 17 (1989) 7116-7123
220. Lima E.S., Bonini M.G., Augusto O., Barbeiro H.V., Souza H.P., and Abdalla D.S.P. Nitrated lipids decompose to nitric oxide and lipid radicals and cause vasorelaxation. Free Radic Biol Med 39 4 (2005) 532-539
221. Linder N., Rapola J., and Raivio K.O. Cellular expression of xanthine oxidoreductase protein in normal human tissues. Lab Invest 79 8 (1999) 967-974
222. Liu J., Ormsby A., Oja-Tebbe N., and Pagano P.J. Gene transfer of NAD(P)H oxidase inhibitor to the vascular adventitia attenuates medial smooth muscle hypertrophy. Circ Res 95 6 (2004) 587-594
223. Liu J., Yang F., Yang X.P., Jankowski M., and Pagano P.J. NAD(P)H oxidase mediates angiotensin II-induced vascular macrophage infiltration and medial hypertrophy. Arterioscler Thromb Vasc Biol 23 5 (2003) 776-782
224. Liu P., Ying Y., and Anderson R.G. Platelet-derived growth factor activates mitogen-activated protein kinase in isolated caveolae. PNAS 94 (1997) 13666-13670
225. Liu P., Ying Y., Ko Y.G., and Anderson R.G.W. Localization of platelet-derived growth factor-stimulated phosphorylation cascade to caveolae. J Biol Chem 271 17 (1996) 10299-10303
226. Lopes N.H., Vasudevan S.S., Gregg D., Selvakumar B., Pagano P.J., Kovacic H., et al. Rac-dependent monocyte chemoattractant protein-1 production is induced by nutrient deprivation. Circ Res 91 (2002) 798-805
227. Mahrouf M., Ouslimani N., Peynet J., Djelidi R., Couturier M., Therond P., et al. Metformin reduces angiotensin-mediated intracellular production of reactive oxygen species in endothelial cells through the inhibition of protein kinase C. Biochem Pharmacol 72 2 (2006) 176-183
228. Marco G., and Michele S. The role of PDE5-inhibitors in cardiopulmonary disorders: from basic evidence to clinical development. Curr Med Chem 14 (2007) 2181-2192
229. Markwardt F., Drawert J., and Walsmann P. Synthetic low molecular weight inhibitors of serum kallikrein. Biochem Pharmacol 23 16 (1974) 2247-2256
230. Markwardt F., Landmann H., and Walsmann P. Comparative studies on the inhibition of trypsin, plasmin, and thrombin by derivatives of benzylamine and benzamidine. Eur J Biochem 6 (1968) 502-506
231. Martyn K.D., Frederick L.M., von Loehneysen K., Dinauer M.C., and Knaus U.G. Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases. Cell Signal 18 1 (2006) 69-82
232. Mason R.P., Kalinowski L., Jacob R.F., Jacoby A.M., and Malinski T. Nebivolol reduces nitroxidative stress and restores nitric oxide bioavailability in endothelium of Black Americans. Circulation 112 24 (2005) 3795-3801
233. Matsuno K., Yamada H., Iwata K., Jin D., Katsuyama M., Matsuki M., et al. Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice. Circulation 112 17 (2005) 2677-2685
234. McCord J.M., and Fridovich I. The reduction of cytochrome c by milk xanthine oxidase. J Biol Chem 243 21 (1968) 5753-5760
235. McNally J.S., Davis M.E., Giddens D.P., Saha A., Hwang J., Dikalov S., et al. Role of xanthine oxidoreductase and NAD(P)H oxidase in endothelial superoxide production in response to oscillatory shear stress. Am J Physiol Heart Circ Physiol 285 6 (2003) H2290-2297
236. McPhail L.C. SH3-dependent assembly of the phagocyte NADPH oxidase. J Exp Med 180 6 (1994) 2011-2015
237. McPhail L.C., DeChatelet L.R., and Shirley P.S. Further characterization of NADPH oxidase activity of human polymorphonuclear leukocytes. J Clin Invest 58 (1976) 774-780
238. Megyeri P., Nemeth L., Pabst K.M., Pabst M.J., Deli M.A., and Abraham C.S. 4-(2-Aminoethyl)benzenesulfonyl fluoride attenuates tumor-necrosis-factor-[alpha]-induced blood-brain barrier opening. Eur J Pharmacol 374 2 (1999) 207-211
239. Megyeri P., Pabst K.M., and Pabst M.J. Serine protease inhibitors block priming of monocytes for enhanced release of superoxide. Immunology 86 (1995) 629-635
240. Meyer J.W., Holland J.A., ZIegler L.M., Chang M.M., Beebe G., and Schmidt M.E. Identification of a functional leukocyte-type NADPH oxidase in human endothelial cells: a potential atherogenic source of reactive oxygen species. Endothelium 7 1 (1999) 11-22
241. Miesel R., Kurpisz M., and Kroger H. Suppression of inflammatory arthritis by simultaneous inhibition of nitric oxide synthase and NADPH oxidase. Free Radic Biol Med 20 1 (1996) 75-81
242. Miller A.A., Drummond G.R., Schmidt H.H.H.W., and Sobey C.G. NADPH oxidase activity and function are profoundly greater in cerebral versus systemic arteries. Circ Res 97 10 (2005) 1055-1062
243. Miriyala S., Gongora Nieto M.C., Mingone C., Smith D., Dikalov S., Harrison D.G., et al. Bone morphogenic protein-4 induces hypertension in mice: role of noggin, vascular NADPH oxidases, and impaired vasorelaxation. Circulation 113 24 (2006) 2818-2825
244. Miyano K., Ueno N., Takeya R., and Sumimoto H. Direct involvement of the small GTPase Rac in activation of the superoxide-producing NADPH oxidase Nox1. J Biol Chem 281 31 (2006) 21857-21868
245. Miyoshi N., Takabayashi S., Osawa T., and Nakamura Y. Benzyl isothiocyanate inhibits excessive superoxide generation in inflammatory leukocytes: implication for prevention against inflammation-related carcinogenesis. Carcinogenesis 25 4 (2004) 567-575
246. Mollnau H., Schulz E., Daiber A., Baldus S., Oelze M., August M., et al. Nebivolol prevents vascular NOS III uncoupling in experimental hyperlipidemia and inhibits NADPH oxidase activity in inflammatory cells. Arterioscler Thromb Vasc Biol 23 4 (2003) 615-621
247. Mollnau H., Wendt M., Szocs K., Lassegue B., Schulz E., Oelze M., et al. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res 90 4 (2002) E58-65
248. Morawietz H., Erbs S., Holtz J., Schubert A., Krekler M., Goettsch W., et al. Endothelial protection, AT1 blockade and cholesterol-dependent oxidative stress: the EPAS trial. Circulation 114 1_suppl (2006) I-296-301
249. Mueller C.F.H., Laude K., McNally J.S., and Harrison D.G. Redox mechanisms in blood vessels. Arterioscler Thromb Vasc Biol 25 2 (2005) 274-278
250. Munzel T., Hink U., Heitzer T., and Meinertz T. Role for NADPH/NADH oxidase in the modulation of vascular tone. Ann NY Acad Sci 874 1 (1999) 386-400
251. Muzaffar S., Shukla N., Srivastava A., Angelini G.D., and Jeremy J.Y. Sildenafil citrate and sildenafil nitrate (NCX 911) are potent inhibitors of superoxide formation and gp91phox expression in porcine pulmonary artery endothelial cells. Br J Pharmacol 146 1 (2005) 109-117
252. Nagel S., Genius J., Heiland S., Horstmann S., Gardner H., and Wagner S. Diphenyleneiodonium and dimethylsulfoxide for treatment of reperfusion injury in cerebral ischemia of the rat. Brain Research 1132 (2007) 210-217
253. Nakamura R., Sumimoto H., Mizuki K., Hata K., Ago T., Kitajima S., et al. The PC motif: a novel and evolutionarily conserved sequence involved in interaction between p40phox and p67phox, SH3 domain-containing cytosolic factors of the phagocyte NADPH oxidase. Eur J Biochem 251 3 (1998) 583-589
254. Nakamura Y., Tsuji K., Shuto M., Ogita K., Yoneda Y., Shimamoto K., et al. Protection by diphenyliodonium against glutamate neurotoxicity due to blocking of N-methyl-aspartate receptors. Neuroscience 76 2 (1997) 459-466
255. Nishida S., Yoshida L.S., Shimoyama T., Nunoi H., Kobayashi T., and Tsunawaki S. Fungal metabolite gliotoxin targets flavocytochrome b558 in the activation of the human neutrophil NADPH oxidase. Infect Immun 73 1 (2005) 235-244
256. Nisimoto Y., Freeman J.L.R., Motalebi S.A., Hirshberg M., and Lambeth J.D. Rac binding to p67phox. Structural basis for interactions of the Rac1 effector region and insert region with components of the respiratory burst oxidase. J Biol Chem 272 30 (1997) 18834-18841
257. Nisimoto Y., Motalebi S., Han C.H., and Lambeth J.D. The p67phox activation domain regulates electron flow from NADPH to flavin in flavocytochrome b558. J Biol Chem 274 33 (1999) 22999-23005
258. Nobuhisa I., Takeya R., Ogura K., Ueno N., Kohda D., Inagaki F., et al. Activation of the superoxide-producing phagocyte NADPH oxidase requires co-operation between the tandem SH3 domains of p47phox in recognition of a polyproline type II helix and an adjacent alpha-helix of p22phox. Biochem J 396 1 (2006) 183-192
259. Noda Y., Kohjima M., Izaki T., Ota K., Yoshinaga S., Inagaki F., et al. Molecular recognition in dimerization between PB1 domains. J Biol Chem 278 44 (2003) 43516-43524
260. O'Donnell B.V., Tew D.G., Jones O.T., and England P.J. Studies on the inhibitory mechanism of iodonium compounds with special reference to neutrophil NADPH oxidase. Biochem J 290 (1993) 41-49
261. O'Donnell V.B., Smith G.C., and Jones O.T. Involvement of phenyl radicals in iodonium inhibition of flavoenzymes. Mol Pharmacol 46 4 (1994) 778-785
262. Oelze M., Daiber A., Brandes R.P., Hortmann M., Wenzel P., Hink U., et al. Nebivolol inhibits superoxide formation by NADPH oxidase and endothelial dysfunction in angiotensin II-treated rats. Hypertension 48 4 (2006) 677-684
263. Ohara Y., Peterson T.E., and Harrison D.G. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 91 6 (1993) 2546-2551
264. Opitz N., Drummond G.R., Selemidis S., Meurer S., and Schmidt H.H.H.W. The 'A's and 'O's of NADPH oxidase regulation: a commentary on "Subcellular localization and function of alternatively spliced Noxo1 isoforms". Free Radic Biol Med 42 2 (2007) 175-179
265. Orrenius S., Gogvadze V., and Zhivotovsky B. Mitochondrial oxidative stress: implications for cell death. Annu Rev Pharmacol Toxicol 47 1 (2007) 143-183
266. Ouslimani N., Peynet J., Bonnefont-Rousselot D., Therond P., Legrand A., and Beaudeux J.L. Metformin decreases intracellular production of reactive oxygen species in aortic endothelial cells. Metabolism 54 6 (2005) 829-834
267. Ozaki M., Kawashima S., Yamashita T., Hirase T., Namiki M., Inoue N., et al. Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice. J Clin Invest 110 3 (2002) 331-340
268. Ozaki Y., Ohashi T., and Niwa Y. A comparative study on the effects of inhibitors of the lipoxygenase pathway on neutrophil function. Inhibitory effects on neutrophil function may not be attributed to inhibition of the lipoxygenase pathway. Biochem Pharmacol 20 (1986) 3481-3488
269. Pacher P., Nivorozhkin A., and Szabo C. Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacol Rev 58 1 (2006) 87-114
270. Paclet M.H.l.n., Henderson L.M., Campion Y., Morel F.O., and Dagher M.C. Localization of Nox2 N-terminus using polyclonal antipeptide antibodies. Biochem J 382 3 (2004) 981-986
271. Pagano P.J., Clark J.K., Cifuentes-Pagano M.E., Clark S.M., Callis G.M., and Quinn M.T. Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin II. Proc Natl Acad Sci 94 26 (1997) 14483-14488
272. Pagano P.J., Ito Y., Tornheim K., Gallop P.M., Tauber A.I., and Cohen R.A. An NADPH oxidase superoxide-generating system in the rabbit aorta. Am J Physiol Heart Circ Physiol 268 6 (1995) H2274-H2280
273. Palmer R.M.J., Ferrige A.G., and Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327 6122 (1987) 524-526
274. Paravicini T., Gulluyan L., Dusting G., and Drummond G. Increased NADPH oxidase activity, gp91phox expression, and endothelium-dependent vasorelaxation during neointima formation in rabbits. Circulation Research 91 (2002) 54-61
275. Paravicini T.M., Chrissobolis S., Drummond G.R., and Sobey C.G. Increased NADPH-oxidase activity and Nox4 expression during chronic hypertension is associated with enhanced cerebral vasodilatation to NADPH in vivo. Stroke 35 2 (2004) 584-589
276. Paravicini T.M., Miller A.A., Drummond G.R., and Sobey C.G. Flow-induced cerebral vasodilatation in vivo involves activation of phosphatidylinositol-3 kinase, NADPH-oxidase, and nitric oxide synthase. J Cereb Blood Flow Metab 26 6 (2006) 836-845
277. Park Y.M., Park M.Y., Suh Y.L., and Park J.B. NAD(P)H oxidase inhibitor prevents blood pressure elevation and cardiovascular hypertrophy in aldosterone-infused rats. Biochem Biophys Res Commun 313 3 (2004) 812-817
278. Parkos C., Allen R., Cochrane C., and Jesaitis A. Purified cytochrome b from human granulocyte plasma membrane is comprised of two polypeptides with relative molecular weights of 91,000 and 22,000. J Clin Invest 80 3 (1987) 732-742
279. Pawate S., Shen Q., Fan F., and Bhat N.R. Redox regulation of glial inflammatory response to lipopolysaccharide and interferongamma. J Neurosci Res 77 15 (2004) 540-551
280. Pedersen T.R., Olsson A.G., Faergeman O., Kjekshus J., Wedel H., Berg K., et al. Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S). Circulation 97 15 (1998) 1453-1460
281. Perry D.K., Hand W.L., Edmondson D.E., and Lambeth J.D. Role of phospholipase D-derived diradylglycerol in the activation of the human neutrophil respiratory burst oxidase. Inhibition by phosphatidic acid phosphohydrolase inhibitors. J Immunol 149 8 (1992) 2749-2758
282. Peshavariya H.M., Dusting G.J., and Selemidis S. Analysis of dihydroethidium fluorescence for the detection of intracellular and extracellular superoxide produced by NADPH oxidase. Free Radic Res 41 6 (2007) 699-712
283. Petry A., Djordjevic T., Weitnauer M., Kietzmann T., Hess J., and Gorlach A. NOX2 and NOX4 mediate proliferative response in endothelial cells. Antioxid Redox Signal 8 9-10 (2006) 1473-1484
284. Pflueger A., Croatt A.J., Peterson T.E., Smith L.A., d'Uscio L.V., Katusic Z.S., et al. The hyperbilirubinemic Gunn rat is resistant to the pressor effects of angiotensin II. Am J Physiol Renal Physiol 288 3 (2005) F552-558
285. Plump A.S., Smith J.D., Hayek T., Aalto-Setala K., Walsh A., Verstuyft J.G., et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71 2 (1992) 343-353
286. Ponting C.P. Novel domains in NADPH oxidase subunits, sorting nexins, and PtdIns 3-kinases: binding partners of SH3 domains?. Protein Sci 5 11 (1996) 2353-2357
287. Poolman T.M., Ng L.L., Farmer P.B., and Manson M.M. Inhibition of the respiratory burst by resveratrol in human monocytes: Correlation with inhibition of PI3K signaling. Free Radic Biol Med 39 1 (2005) 118-132
288. Post M.J., Sato K., Murakami M., Bao J., Tirziu D., Pearlman J.D., et al. Adenoviral PR39 improves blood flow and myocardial function in a pig model of chronic myocardial ischemia by enhancing collateral formation. Am J Physiol Regul Integr Comp Physiol 290 3 (2006) R494-500
289. Qin F., Simeone M., and Patel R. Inhibition of NADPH oxidase reduces myocardial oxidative stress and apoptosis and improves cardiac function in heart failure after myocardial infarction. Free Radic Biol Med 43 2 (2007) 271-281
290. Rajagopalan S., Kurz S., Munzel T., Tarpey M., Freeman B.A., Griendling K.K., et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 97 8 (1996) 1916-1923
291. Ragan C.I., and Bloxham D.P. Specific labelling of a constituent polypeptide of bovine heart mitochondrial reduced nicotinamide-adenine dinucleotide-ubiquinone reductase by the inhibitor diphenyleneiodonium. Biochem J 163 3 (1977) 605-615
292. Regazzi R., Kikuchi A., Takai Y., and Wollheim C.B. The small GTP-binding proteins in the cytosol of insulin-secreting cells are complexed to GDP dissociation inhibitor proteins. J Biol Chem 267 25 (1992) 17512-17519
293. Remold-O'Donnell E., and Parent D. Downregulation of neutrophil CD43 by opsonized zymosan. Blood 85 2 (1995) 337-342
294. Rey F.E., Cifuentes M.E., Kiarash A., Quinn M.T., and Pagano P.J. Novel competitive inhibitor of NAD(P)H oxidase assembly attenuates vascular O(2)(-) and systolic blood pressure in mice. Circ Res 89 (2001) 408-414
295. Rey F.E., Li X.C., Carretero O.A., Garvin J.L., and Pagano P.J. Perivascular superoxide anion contributes to impairment of endothelium- dependent relaxation: role of gp91(phox). Circulation 106 19 (2002) 2497-2502
296. Riganti C., Gazzano E., Polimeni M., Costamagna C., Bosia A., and Ghigo D. Diphenyleneiodonium inhibits the cell redox metabolism and induces oxidative stress. J Biol Chem 279 46 (2004) 47726-47731
297. Ris-Stalpers C. Physiology and pathophysiology of the DUOXes. Antioxid Redox Signal 8 9-10 (2006) 1563-1572
298. Rolfe R.D., and Finegold S.M. Purification and characterization of Clostridium difficile toxin. Infect Immun 25 1 (1979) 191-201
299. Rosenblat M., and Aviram M. Oxysterol-induced activation of macrophage NADPH-oxidase enhances cell-mediated oxidation of LDL in the atherosclerotic apolipoprotein E deficient mouse: inhibitory role for vitamin E. Atherosclerosis 160 1 (2002) 69-80
300. Rossary A., Arab K., and Steghens J.P. Polyunsaturated fatty acids modulate NOX 4 anion superoxide production in human fibroblasts. Biochem J 406 1 (2007) 77-83
301. Rossi F., and Zatti M. Biochemical aspects of phagocytosis in polymorphonuclear leucocytes. NADH and NADPH oxidation by the granules of resting and phagocytizing cells. Experientia 20 1 (1963) 21-23
302. Rotrosen D., and Leto T.L. Phosphorylation of neutrophil 47-kDa cytosolic oxidase factor. Translocation to membrane is associated with distinct phosphorylation events. J Biol Chem 265 32 (1990) 19910-19915
303. Rueckschloss U., Galle J., Holtz J., Zerkowski H.R., and Morawietz H. Induction of NAD(P)H oxidase by oxidized low-density lipoprotein in human endothelial cells: antioxidative potential of hydroxymethylglutaryl coenzyme A reductase inhibitor therapy. Circulation 104 15 (2001) 1767-1772
304. Sacks F.M., Moye L.A., Davis B.R., Cole T.G., Rouleau J.L., Nash D.T., et al. Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the cholesterol and recurrent events trial. Circulation 97 15 (1998) 1446-1452
305. Sacks F.M., Pfeffer M.A., Moye L.A., Rouleau J.L., Rutherford J.D., Cole T.G., et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 335 14 (1996) 1001-1009
306. San Martin A., Foncea R., Laurindo F.R., Ebensperger R., Griendling K.K., and Leighton F. Nox1-based NADPH oxidase-derived superoxide is required for VSMC activation by advanced glycation end-products. Free Radic Biol Med 42 11 (2007) 1671-1679
307. Sarfstein R., Gorzalczany Y., Mizrahi A., Berdichevsky Y., Molshanski-Mor S., Weinbaum C., et al. Dual role of Rac in the assembly of NADPH oxidase, tethering to the membrane and activation of p67phox: A study based on mutagenesis of p67phox-Rac1 chimeras. J Biol Chem 279 16 (2004) 16007-16016
308. Schroder K., Helmcke I., Palfi K., Krause K.H., Busse R., and Brandes R.P. Nox1 mediates basic fibroblast growth factor-induced migration of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 27 8 (2007) 1736-1743
309. Schubert M.L. Gastric secretion. Curr Opin Gastroenterol 23 6 (2007) 595-601
310. Segal A.W. How neutrophils kill microbes. Ann Rev Immunol 23 1 (2005) 197-223
311. Segal A.W., and Jones D.T. Novel cytochrome b system in phagocytic vacuoles of human granulocytes. Nature 276 (1978) 515-517
312. Sehr P., Joseph G., Genth H., Just I., Pick E., and Aktories K. Glucosylation and ADP ribosylation of rho proteins: effects on nucleotide binding, GTPase activity, and effector coupling. Biochemistry 37 15 (1998) 5296-5304
313. Seifert R., Wenzel K., Eckstein F., and Schultz G. Purine and pyrimidine nucleotides potentiate activation of NADPH oxidase and degranulation by chemotactic peptides and induce aggregation of human neutrophils via G proteins. Eur J Biochem 181 1 (1989) 277-285
314. Selemidis S., Dusting G.J., Peshavariya H., Kemp-Harper B.K., and Drummond G.R. Nitric oxide suppresses NADPH oxidase-dependent superoxide production by S-nitrosylation in human endothelial cells. Cardiovasc Res 75 2 (2007) 349-358
315. Serrander L., Cartier L., Bedard K., Banfi B., Lardy B., Plastre O., et al. NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation. Biochem J 406 1 (2007) 105-114
316. Seshiah P.N., Weber D.S., Rocic P., Valppu L., Taniyama Y., and Griendling K.K. Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators. Circ Res 91 5 (2002) 406-413
317. Shatrov V.A., Sumbayev V.V., Zhou J., and Brune B. Oxidized low-density lipoprotein (oxLDL) triggers hypoxia-inducible factor-1{alpha} (HIF-1{alpha}) accumulation via redox-dependent mechanisms. Blood 101 12 (2003) 4847-4849
318. Shepherd J., Cobbe S.M., Ford I., Isles C.G., Lorimer A.R., Macfarlane P.W., et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 333 20 (1995) 1301-1308
319. Shi J., Ross C.R., Leto T.L., and Blecha F. PR-39, a proline-rich antibacterial peptide that inhibits phagocyte NADPH oxidase activity by binding to Src homology 3 domains of p47phox. PNAS 93 12 (1996) 6014-6018
320. Shin H.K., Lee J.H., Kim K.Y., Kim C.D., Lee W.S., Rhim B.Y., et al. Impairment of autoregulatory vasodilation by NAD(P)H oxidase-dependent superoxide generation during acute stage of subarachnoid hemorrhage in rat pial artery. J Cereb Blood Flow Metab 22 7 (2002) 869-877
321. Shiose A., Kuroda J., Tsuruya K., Hirai M., Hirakata H., Naito S., et al. A novel superoxide-producing NAD(P)H oxidase in kidney. J Biol Chem 276 2 (2001) 1417-1423
322. Shukla N., Jones R., Persad R., Angelini G.D., and Jeremy J.Y. Effect of sildenafil citrate and a nitric oxide donating sildenafil derivative, NCX 911, on cavernosal relaxation and superoxide formation in hypercholesterolaemic rabbits. Eur J Pharmacol 517 3 (2005) 224-231
323. Sicard P., Acar N., Gregoire S., Lauzier B., Bron A.M., Creuzot-Garcher C., et al. Influence of rosuvastatin on the NAD(P)H oxidase activity in the retina and electroretinographic response of spontaneously hypertensive rats. Br J Pharmacol 151 7 (2007) 979-986
324. Simes R.J., Marschner I.C., Hunt D., Colquhoun D., Sullivan D., Stewart R.A.H., et al. Relationship between lipid levels and clinical outcomes in the long-term intervention with pravastatin in ischemic disease (LIPID) trial: to what extent is the reduction in coronary events with pravastatin explained by on-study lipid levels?. Circulation 105 10 (2002) 1162-1169
325. Simmons D.L., Botting R.M., and Hla T. Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol Rev 56 3 (2004) 387-437
326. Simons J.M., Hart L.A., van Dijk H., Fischer F.C., de Silva K.T., and Labadie R.P. Immunodulatory compounds from Picrorhiza kurroa: isolation and characterization of two anti-complementary polymeric fractions from an aqueous root extract. J Ethnopharmacol 26 2 (1989) 169-182
327. Simons J.M., 'T Hart B.A., Theo R.A.M., Ching I.V., Duk H.V., and Labadie R.P. Metabolic activation of natural phenols into selective oxidative burst agonists by activated human neutrophils. Free Rad Biol & Med 8 (1990) 251-258
328. Sobey C.G., and Faraci F.M. Subarachnoid haemorrhage: what happens to the cerebral arteries?. Clin Exp Pharmacol Physiol 25 11 (1998) 867-876
329. Sohn H.Y., Krotz F., Gloe T., Keller M., Theisen K., Klauss V., et al. Differential regulation of xanthine and NAD(P)H oxidase by hypoxia in human umbilical vein endothelial cells. Role of nitric oxide and adenosine. Cardiovasc Res 58 3 (2003) 638-646
330. Sorescu D., Weiss D., Lassegue B., Clempus R.E., Szocs K., Sorescu G.P., et al. Superoxide production and expression of Nox family proteins in human atherosclerosis. Circulation 105 12 (2002) 1429-1435
331. Sorescu G.P., Song H., Tressel S.L., Hwang J., Dikalov S., Smith D.A., et al. Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress induces monocyte adhesion by stimulating reactive oxygen species production from a Nox1-based NADPH oxidase. Circ Res 95 (2004) 773-779
332. Soslau G., Class R., Morgan D.A., Foster C., Lord S.T., Marchese P., et al. Unique pathway of thrombin-induced platelet aggregation mediated by glycoprotein Ib. J Biol Chem 276 24 (2001) 21173-21183
333. Stielow C., Catar R.A., Muller G., Wingler K., Scheurer P., Schmidt H.H.H.W., et al. Novel Nox inhibitor of oxLDL-induced reactive oxygen species formation in human endothelial cells. Biochem Biophys Res Commun 344 1 (2006) 200-205
334. Stocker R., and Keaney Jr. J.F. Role of oxidative modifications in atherosclerosis. Physiol Rev 84 4 (2004) 1381-1478
335. Stolk J., Hiltermann T.J., Dijkman J.H., and Verhoeven A.J. Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol. Am J Respir Cell Mol Biol 11 1 (1994) 95-102
336. Stroes E., Hijmering M., van Zandvoort M., Wever R., Rabelink T.J., and van Faassen E.E. Origin of superoxide production by endothelial nitric oxide synthase. FEBS Lett 438 3 (1998) 161-164
337. Stuehr D.J., Fasehun O.A., Kwon N.S., Gross S.S., Gonzalez J.A., Levi R., et al. Inhibition of macrophage and endothelial cell nitric oxide synthase by diphenyleneiodonium and its analogs. FASEB J 5 1 (1991) 98-103
338. Suh Y.A., Arnold R.S., Lassegue B., Shi J., Xu X., Sorescu D., et al. Cell transformation by the superoxide-generating oxidase Mox1. Nature 401 (1999) 79-82
339. Sumimoto H., Kage Y., Nunoi H., Sasaki H., Nose T., Fukumaki Y., et al. Role of Src homology 3 domains in assembly and activated of the phagocyte NADPH oxidase. PNAS 91 12 (1994) 5345-5349
340. Sumimoto H., Miyano K., and Takeya R. Molecular composition and regulation of the Nox family NAD(P)H oxidases. Biochem Biophys Res Commun 338 1 (2005) 677-686
341. Sun Y., Asnicar M., and Smith R.G. Central and peripheral roles of ghrelin on glucose homeostasis. Neuroendocrinology 86 3 (2007) 215-228
342. Szanto I., Rubbia-Brandt L., Kiss P., Steger K., Banfi B., Kovari E., et al. Expression of NOX1, a superoxide-generating NADPH oxidase, in colon cancer and inflammatory bowel disease. J Pathol 207 2 (2005) 164-176
343. Taille C., El-Benna J., Lanone S., Dang M.C., Ogier-Denis E., Aubier M., et al. Induction of heme oxygenase-1 inhibits NAD(P)H oxidase activity by down-regulating cytochrome b558 expression via the reduction of heme availability. J Biol Chem 279 27 (2004) 28681-28688
344. Tamura M., Shiozaki I., Ono S., Miyano K., Kunihiro S., and Sasaki T. p40phox as an alternative organizer to p47phox in Nox2 activation: a new mechanism involving an interaction with p22phox. FEBS Lett 581 23 (2007) 4533-4538
345. Tang L.L., Ye K., Yang X.F., and Zheng J.S. Apocynin attenuates cerebral infarction after transient focal ischaemia in rats. J Int Med Res 35 (2007) 517-522
346. Taylor N.S., and Bartlett J.G. Partial purification and characterization of a cytotoxin from Clostridium difficile. Rev Infect Dis 2 1 (1979) 379-385
347. Taylor R.M., Baniulis D., Burritt J.B., Gripentrog J.M., Lord C.I., Riesselman M.H., et al. Analysis of human phagocyte flavocytochrome b558 by mass spectrometry. J Biol Chem 281 48 (2006) 37045-37056
348. Taylor R.M., Burritt J.B., Baniulis D., Foubert T.R., Lord C.I., Dinauer M.C., et al. Site-specific inhibitors of NADPH oxidase activity and structural probes of flavocytochrome b: characterization of six monoclonal antibodies to the p22phox subunit. J Immunol 173 12 (2004) 7349-7357
349. Taylor W.R., Jones D.T., and Segal A.W. A structural model for the nucleotide binding domains of the flavocytochrome b(-245) {beta}-chain. Protein Sci 2 10 (1993) 1675-1685
350. Tegtmeier, F., Schnizel, R., Wingler, K., Scheurer, P., & HHHW, Schmidt (2005) Compounds containing a N-heteroaryl moiety linked to fused ring moieties for the inhibition of NAD(P)H oxidases and platelet activation. EP 1 598 354 A1 (PCT patent WO 2005/111041 A1).
351. ten Freyhaus H., Huntgeburth M., Wingler K., Schnitker J., Baumer A.T., Vantler M., et al. Novel Nox inhibitor VAS2870 attenuates PDGF-dependent smooth muscle cell chemotaxis, but not proliferation. Cardiovasc Res 71 2 (2006) 331-341
352. 't Hart B.A., Simons J.M., Knaan-Shanzer S., Bakker N.P., and Labadie R.P. Antiarthritic activity of the newly developed neutrophil oxidative burst antagonist apocynin. Free Radic Biol Med 9 2 (1990) 127-131
353. The Scandinavian Simvastatin Survival Study (4S). Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344 8934 (1994) 1383-1389
354. Tiefenbacher C.P., Bleeke T., Vahl C., Amann K., Vogt A., and Kubler W. Endothelial dysfunction of coronary resistance arteries is improved by tetrahydrobiopterin in atherosclerosis. Circulation 102 18 (2000) 2172-2179
355. Tisch D., Sharoni Y., Danilenko M., and Aviram I. The assembly of neutrophil NADPH oxidase: effects of mastoparan and its synthetic analogues. Biochem J 310 (1995) 715-719
356. Tisch-Idelson D., Fridkin M., Wientjes F., and Aviram I. Structure-function relationship in the interaction of mastoparan analogs with neutrophil NADPH oxidase. Biochem Pharmacol 61 9 (2001) 1063-1071
357. Touyz R.M., and Berry C. Recent advances in angiotensin II signaling. Braz J Med Biol Res 35 9 (2002) 1001-1015
358. Touyz R.M., Chen X., Tabet F., Yao G., He G., Quinn M.T., et al. Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II. Circ Res 90 11 (2002) 1205-1213
359. Touyz R.M., Mercure C., He Y., Javeshghani D., Yao G., Callera G.E., et al. Angiotensin II-dependent chronic hypertension and cardiac hypertrophy are unaffected by gp91phox-containing NADPH oxidase. Hypertension 45 4 (2005) 530-537
360. Troost R., Schwedhelm E., Rojczyk S., Tsikas D., and Frolich J.C. Nebivolol decreases systemic oxidative stress in healthy volunteers. Br J Clin Pharmacol 50 4 (2000) 377-379
361. Tsunawaki S., and Nathan C.F. Release of arachidonate and reduction of oxygen. Independent metabolic bursts of the mouse peritoneal macrophage. J Biol Chem 261 25 (1986) 11563-11570
362. Tsunawaki S., Yoshida L.S., Nishida S., Kobayashi T., and Shimoyama T. Fungal metabolite gliotoxin inhibits assembly of the human respiratory burst NADPH oxidase. Infect Immun 72 6 (2004) 3373-3382
363. Turrens J.F. Mitochondrial formation of reactive oxygen species. J Physiol Online 552 2 (2003) 335-344
364. Ueyama T., Lekstrom K., Tsujibe S., Saito N., and Leto T.L. Subcellular localization and function of alternatively spliced Noxo1 isoforms. Free Radic Biol Med 42 2 (2007) 180-190
365. Umeji K., Umemoto S., Itoh S., Tanaka M., Kawahara S., Fukai T., et al. Comparative effects of pitavastatin and probucol on oxidative stress, Cu/Zn superoxide dismutase, PPAR-{gamma}, and aortic stiffness in hypercholesterolemia. Am J Physiol Heart Circ Physiol 291 5 (2006) H2522-2532
366. Van den Worm E., Beukelman C.J., Van den Berg A.J.J., Kroes B.H., Labadie R.P., and Van Dijk H. Effects of methoxylation of apocynin and analogs on the inhibition of reactive oxygen species production by stimulated human neutrophils. Eur J Pharmacol 433 2-3 (2001) 225-230
367. Vasquez-Vivar J., and Kalyanaraman B. Generation of superoxide from nitric oxide synthase. FEBS Lett 481 3 (2000) 305-306
368. Vasquez-Vivar J., Kalyanaraman B., Martasek P., Hogg N., Masters B.S.S., Karoui H., et al. Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. PNAS 95 16 (1998) 9220-9225
369. Vendrov A.E., Hakim Z.S., Madamanchi N.R., Rojas M., Madamanchi C., and Runge M.S. Atherosclerosis is attenuated by limiting superoxide generation in both macrophages and vessel wall cells. Arterioscler Thromb Vasc Biol 27 12 (2007) 2714-2721
370. Venugopal S.K., Devaraj S., Yang T., and Jialal I. alpha-Tocopherol decreases superoxide anion release in human monocytes under hyperglycemic conditions via inhibition of protein kinase C-alpha. Diabetes 51 10 (2002) 3049-3054
371. Vignais P.V. The superoxide-generating NADPH oxidase: structural aspects and activation mechanism. Cell Mol Life Sci 59 (2002) 1428-1459
372. Virdis A., Colucci R., Fornai M., Duranti E., Giannarelli C., Bernardini N., et al. Cyclooxygenase-1 is involved in endothelial dysfunction of mesenteric small arteries from angiotensin II-infused mice. Hypertension 49 3 (2007) 679-686
373. Virdis A., Neves M.F., Amiri F., Touyz R.M., and Schiffrin E.L. Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice. J Hypertens 22 3 (2004) 535-542
374. Wagner A.H., Schroeter M.R., and Hecker M. 17beta-estradiol inhibition of NADPH oxidase expression in human endothelial cells. Faseb J 15 12 (2001) 2121-2130
375. Walch L., Massade L., Dufilho M., Brunet A., and Rendu F. Pro-atherogenic effect of interleukin-4 in endothelial cells: modulation of oxidative stress, nitric oxide and monocyte chemoattractant protein-1 expression. Atherosclerosis 187 2 (2006) 285-291
376. Walder C.E., Green S.P., Darbonne W.C., Mathias J., Rae J., Dinauer M.C., et al. Ischemic stroke injury is reduced in mice lacking a functional NADPH oxidase. Stroke 28 11 (1997) 2252-2258
377. Wallach T., and Segal A. Analysis of glycosylation sites on gp91phox, the flavocytochrome of the NADPH oxidase, by site-directed mutagenesis and translation in vitro. Biochem J 321 Pt3 (1997) 583-585
378. Wang H.D., Xu S., Johns D.G., Du Y., Quinn M.T., Cayatte A.J., et al. Role of NADPH oxidase in the vascular hypertrophic and oxidative stress response to angiotensin II in mice. Circ Res 88 9 (2001) 947-953
379. Wang Q., Smith R.E., Luchtefeld R., Sun A.Y., Simonyi A., Luo R., et al. Bioavailabity of apocynin through its conversion to glycoconjugate but not to diapocynin. Phytomedicine 15 6-7 (2008) 496-503
380. Wang Q., Tompkins K.D., Simonyi A., Korthuis R.J., Sun A.Y., and Sun G.Y. Apocynin protects against global cerebral ischemia-reperfusion-induced oxidative stress and injury in the gerbil hippocampus. Brain Res 1090 1 (2006) 182-189
381. Wang Y.X., and Pang C.C. Functional integrity of the central and sympathetic nervous systems is a prerequisite for pressor and tachycardic effects of diphenyleneiodonium, a novel inhibitor of nitric oxide synthase. J Pharmacol Exp Ther 265 1 (1993) 263-272
382. Wang Y.X., and Pang C.C. Effects of adrenalectomy and chemical sympathectomy on pressor and tachycardic responses to diphenyleneiodonium. J Pharmacol Exp Ther 269 2 (1994) 463-469
383. Wartenberg M., Hoffmann E., Schwindt H., Grunheck F., Petros J., Arnold J.R.S., et al. Reactive oxygen species-linked regulation of the multidrug resistance transporter P-glycoprotein in Nox-1 overexpressing prostate tumor spheroids. FEBS Lett 579 20 (2005) 4541-4549
384. Wassmann S., Laufs U., Baumer A.T., Muller K., Ahlbory K., Linz W., et al. HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species. Hypertension 37 6 (2001) 1450-1457
385. Wassmann S., Laufs U., Muller K., Konkol C., Ahlbory K., Baumer A.T., et al. Cellular antioxidant effects of atorvastatin in vitro and in vivo. Arterioscler Thromb Vasc Biol 22 2 (2002) 300-305
386. Waters D., Higginson L., Gladstone P., Kimball B., Le May M., Boccuzzi S.J., et al. Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial. Circulation 89 3 (1994) 959-968
387. Weaver M., Liu J., Pimentel D., Reddy D.J., Harding P., Peterson E.L., et al. Adventitial delivery of dominant-negative p67phox attenuates neointimal hyperplasia of the rat carotid artery. Am J Physiol Heart Circ Physiology 290 5 (2006) H1933-H1941
388. Weir E.K., Wyatt C.N., Reeve H.L., Huang J., Archer S.L., and Peers C. Diphenyleneiodonium inhibits both potassium and calcium currents in isolated pulmonary artery smooth muscle cells. J Appl Physiol 76 6 (1994) 2611-2615
389. Wendt M.C., Daiber A., Kleschyov A.L., Mulsch A., Sydow K., Schulz E., et al. Differential effects of diabetes on the expression of the gp91phox homologues nox1 and nox4. Free Radic Biol Med 39 3 (2005) 381-391
390. Werner E. GTPases and reactive oxygen species: switches for killing and signaling. J Cell Sci 117 2 (2004) 143-153
391. Williams H.C., and Griendling K.K. NADPH oxidase inhibitors: new antihypertensive agents?. J Cardiovasc Pharmacol 50 1 (2007) 9-16
392. Wingler K., Wunsch S., Kreutz R., Rothermund L., Paul M., and Schmidt H.H. Upregulation of the vascular NAD(P)H-oxidase isoforms Nox1 and Nox4 by the renin-angiotensin system in vitro and in vivo. Free Radic Biol Med 31 11 (2001) 1456-1464
393. Wittwer J., and Hersberger M. The two faces of the 15-lipoxygenase in atherosclerosis. Prostaglandins Leukot Essent Fat Acids 77 2 (2007) 67-77
394. Xiao D., Vogel V., and SIngh S.V. Benzyl isothiocyanate-induced apoptosis in human breast cancer cells is initiated by reactive oxygen species and regulated by Bax and Bak. Mol Cancer Ther 11 (2006) 2931-2945
395. Ximenes V.F., Kanegae M.P., Rissato S.R., and Galhiane M.S. The oxidation of apocynin catalyzed by myeloperoxidase: proposal for NADPH oxidase inhibition. Arch Biochem Biophys 457 (2007) 134-141
396. Yang M., Foster E., and Kahn A.M. Insulin-stimulated NAD(P)H oxidase activity increases migration of cultured vascular smooth muscle cells. Am J Hypertens 18 10 (2005) 1329-1334
397. Yang S., Madyastha P., Bingel S., Ries W., and Key L. A new superoxide-generating oxidase in murine osteoclasts. J Biol Chem 276 8 (2001) 5452-5458
398. Yibin G., Jiang Z., Hong Z., Gengfa L., Liangxi W., Guo W., et al. A synthesized cationic tetradecapeptide from hornet venom kills bacteria and neutralizes lipopolysaccharide in vivo and in vitro. Biochem Pharmacol 70 2 (2005) 209-219
399. Yogi A., Mercure C., Touyz J., Callera G.E., Montezano A.C., Aranha A.B., et al. Renal redox-sensitive signaling, but not blood pressure, is attenuated by Nox1 knockout in angiotensin II-dependent chronic hypertension. Hypertension 51 2 (2008) 500-506
400. Yokoyama M., Inoue N., and Kawashima S. Role of the vascular NADH/NADPH oxidase system in atherosclerosis. Ann N Y Acad Sci 902 1 (2000) 241-248
401. Yoshida L.S., Abe S., and Tsunawaki S. Fungal gliotoxin targets the onset of superoxide-generating NADPH oxidase of human neutrophils. Biochem Biophys Res Commun 268 3 (2000) 716-723
402. Yuzawa S., Ogura K., Horiuchi M., Suzuki N.N., Fujioka Y., Kataoka M., et al. Solution structure of the tandem Src homology 3 domains of p47phox in an autoinhibited form. J Biol Chem 279 28 (2004) 29752-29760
403. Zang M., Xu S., Maitland-Toolan K.A., Zuccollo A., Hou X., Jiang B., et al. Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice. Diabetes 55 8 (2006) 2180-2191
404. Zangar R.C., Davydov D.R., and Verma S. Mechanisms that regulate production of reactive oxygen species by cytochrome P450. Toxicol Appl Pharmacol 199 3 (2004) 316-331
405. Zhang Y., Chan M.M.K., Andrews M.C., Mori T.A., Croft K.D., McKenzie K.U.S., et al. Apocynin but not allopurinol prevents and reverses adrenocorticotropic hormone-induced hypertension in the rat. Am J Hypertens 18 7 (2005) 910-916
406. Zhu Y., Marchal C.C., Casbon A.J., Stull N., von Lohneysen K., Knaus U.G., et al. Deletion mutagenesis of p22phox subunit of flavocytochrome b558: Identification of regions critical for gp91phox maturation and NADPH Oxidase Activity. J Biol Chem 281 41 (2006) 30336-30346